Another ESC recap, listener feedback on two trials, and a paper on GLP-1 effects on inflammation from the SELECT trial are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Correction on PROFID Trial
II Listener Feedback
III Fifth Universal Definition of MI
- Fifth Universal Definition of MI https://doi.org/10.1093/eurheartj/ehag101
- Foy/Mandrola Editorial on Troponin Use and Interpretation https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2777967
IV New ESC HF Guidelines
- ESC Guidelines for Management of HF https://doi.org/10.1093/eurheartj/ehag100
- Sanjay Kaul on X https://x.com/kaulcsmc/status/2094959683215958158?s=20
- Geographic Disparities in TOPCAT https://pmc.ncbi.nlm.nih.gov/articles/PMC5065247/
V AIR STEMI Trial
- AIR-STEMI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2605373
- CR Strategies After MI https://www.jacc.org/doi/10.1016/j.jacc.2024.04.051
- PRAMI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1305520
- COMPLETE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1907775
- FULL REVASC Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2314149
VI GLP-1 News – A SELECT Trial Secondary Analysis
- Semaglutide and hsCRP in Patients with CVD and Obesity https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.125.074482
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
